SHALLCROSS STEVEN A 4
4 · Synthetic Biologics, Inc. · Filed Dec 31, 2020
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Award
Stock Options
2020-12-30+450,000→ 450,000 totalExercise: $0.42From: 2021-01-30Exp: 2027-12-30→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]These stock options will vest pro rata on a monthly basis over 36 months.